mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.1 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |